Apple (AAPL) 10-Q 28 Jan 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Dec. 28, 2013	Jan. 10, 2014
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	28-Dec-13	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'
Trading Symbol	'AAPL	'
Entity Registrant Name	'APPLE INC	'
Entity Central Index Key	'0000320193	'
Current Fiscal Year End Date	'--09-27	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	891,989,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012
Net sales	$57,594	$54,512
Cost of sales	35,748	33,452
Gross margin	21,846	21,060
Operating expenses:	'	'
Research and development	1,330	1,010
Selling, general and administrative	3,053	2,840
Total operating expenses	4,383	3,850
Operating income	17,463	17,210
Other income/(expense), net	246	462
Income before provision for income taxes	17,709	17,672
Provision for income taxes	4,637	4,594
Net income	$13,072	$13,078
Earnings per share:	'	'
Basic	$14.59	$13.93
Diluted	$14.50	$13.81
Shares used in computing earnings per share:	'	'
Basic	896,072	938,916
Diluted	901,452	947,217
Cash dividends declared per common share	$3.05	$2.65

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012
Net income	$13,072	$13,078
Other comprehensive income/(loss):	'	'
Change in foreign currency translation, net of tax	-67	-26
Change in unrecognized gains/losses on derivative instruments:	'	'
Change in fair value of derivatives, net of tax	213	146
Adjustment for net (gains)/losses realized and included in net income, net of tax	72	112
Total change in unrecognized gains/losses on derivative instruments, net of tax	285	258
Change in unrealized gains/losses on marketable securities:	'	'
Change in fair value of marketable securities, net of tax	-42	-66
Adjustment for net (gains)/losses realized and included in net income, net of tax	-11	-53
Total change in unrealized gains/losses on marketable securities, net of tax	-53	-119
Total other comprehensive income/(loss)	165	113
Total comprehensive income	$13,237	$13,191

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Dec. 28, 2013	Sep. 28, 2013
In Millions, unless otherwise specified
Current assets:	'	'
Cash and Cash Equivalents	$14,077	$14,259
Short-term marketable securities	26,634	26,287
Accounts receivable, less allowances of $94 and $99, respectively	14,200	13,102
Inventories	2,122	1,764
Deferred tax assets	3,742	3,453
Vendor non-trade receivables	10,998	7,539
Other current assets	8,574	6,882
Total current assets	80,347	73,286
Long-term marketable securities	118,131	106,215
Property, plant and equipment, net	15,488	16,597
Goodwill	2,022	1,577
Acquired intangible assets, net	4,105	4,179
Other assets	5,091	5,146
Total assets	225,184	207,000
Current liabilities:	'	'
Accounts payable	29,588	22,367
Accrued expenses	15,824	13,856
Deferred revenue	8,357	7,435
Total current liabilities	53,769	43,658
Deferred revenue - non-current	3,071	2,625
Long-term debt	16,961	16,960
Other non-current liabilities	21,699	20,208
Total liabilities	95,500	83,451
Commitments and contingencies	'	'
Shareholders' equity:	'	'
Common stock, no par value; 1,800,000 shares authorized; 892,447 and 899,213 shares issued and outstanding, respectively	20,559	19,764
Retained earnings	109,431	104,256
Accumulated other comprehensive income/(loss)	-306	-471
Total shareholders' equity	129,684	123,549
Total liabilities and shareholders' equity	$225,184	$207,000

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 28, 2013	Sep. 28, 2013
In Millions, except Share data in Thousands, unless otherwise specified
Accounts receivable, allowances	$94	$99
Common stock, no par value	'	'
Common stock, shares authorized	1,800,000	1,800,000
Common stock, shares issued	892,447	899,213
Common stock, shares outstanding	892,447	899,213

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012
Cash and cash equivalents, beginning of the period	$14,259	$10,746
Operating activities:	'	'
Net income	13,072	13,078
Adjustments to reconcile net income to cash generated by operating activities:	'	'
Depreciation and amortization	2,144	1,588
Share-based compensation expense	681	545
Deferred income tax expense	1,253	1,179
Changes in operating assets and liabilities:	'	'
Accounts receivable, net	-1,098	-668
Inventories	-358	-664
Vendor non-trade receivables	-3,459	-2,174
Other current and non-current assets	-319	413
Accounts payable	8,191	6,145
Deferred revenue	1,368	1,611
Other current and non-current liabilities	1,195	2,373
Cash generated by operating activities	22,670	23,426
Investing activities:	'	'
Purchases of marketable securities	-48,397	-37,192
Proceeds from maturities of marketable securities	5,556	3,460
Proceeds from sales of marketable securities	30,302	23,002
Payments made in connection with business acquisitions, net	-525	-284
Payments for acquisition of property, plant and equipment	-1,985	-2,317
Payments for acquisition of intangible assets	-59	-138
Other	5	-52
Cash used in investing activities	-15,103	-13,521
Financing activities:	'	'
Proceeds from issuance of common stock	134	76
Excess tax benefits from equity awards	280	404
Taxes paid related to net share settlement of equity awards	-365	-534
Dividends and dividend equivalents paid	-2,769	-2,493
Repurchase of common stock	-5,029	-1,950
Cash used in financing activities	-7,749	-4,497
Increase/(decrease) in cash and cash equivalents	-182	5,408
Cash and cash equivalents, end of the period	14,077	16,154
Supplemental cash flow disclosure:	'	'
Cash paid for income taxes, net	3,387	1,890
Cash paid for interest	$161	$0

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Dec. 28, 2013
Summary of Significant Accounting Policies	'
	Note 1 – Summary of Significant Accounting Policies
	Apple Inc. and its wholly-owned subsidiaries (collectively “Apple” or the “Company”) designs, manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and applications. The Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the Company sells a variety of third-party iPhone, iPad, Mac, and iPod compatible products, including application software, and various accessories through its online and retail stores. The Company sells to consumers; small and mid-sized businesses; and education, enterprise and government customers.
	Basis of Presentation and Preparation
	The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.
	These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and the notes thereto for the fiscal year ended September 28, 2013, included in its Annual Report on Form 10-K (the “2013 Form 10-K”). The Company’s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter approximately every six years to realign fiscal quarters with calendar quarters. The Company’s fiscal years 2014 and 2013 each include 52 weeks. Unless otherwise stated, references to particular years, quarters or months refer to the Company’s fiscal years ended in September and the associated quarters or months of those fiscal years.
	During the first quarter of 2014, the Company adopted updated accounting standards that (i) required disclosure of additional information about the amounts reclassified out of Accumulated Other Comprehensive Income (“AOCI”) by component and (ii) required gross and net disclosures about offsetting assets and liabilities. The adoption of these updated standards only impacted the disclosures in the Notes to the Condensed Consolidated Financial Statements; accordingly, the adoption had no impact on the Company’s financial position or results of operations. The Company has provided these additional disclosures in this Form 10-Q in Note 8, “Comprehensive Income” and Note 2, “Financial Instruments,” respectively.
	Revenue Recognition
	In 2013, the Company’s combined best estimates of selling price (“ESPs”) for the unspecified software upgrade rights and the rights to receive the non-software services included with its qualifying hardware devices ranged from $5 to $25. Beginning in the first quarter of 2014, the Company adjusted the combined ESPs for Mac from $20 to $40 to reflect additions to unspecified software upgrade rights related to expansion of bundled essential software.
	Earnings Per Share
	Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company’s employee stock purchase plan and unvested restricted stock units (“RSUs”). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s common stock can result in a greater dilutive effect from potentially dilutive securities.
	The following table shows the computation of basic and diluted earnings per share for the three months ended December 28, 2013 and December 29, 2012 (in thousands, except net income in millions and per share amounts):
		Three Months Ended
		December 28,		December 29,
		2013		2012
	Numerator:
	Net income	$	13,072	$	13,078
	Denominator:
	Weighted-average shares outstanding		896,072		938,916
	Effect of dilutive securities		5,380		8,301
	Weighted-average diluted shares		901,452		947,217
	Basic earnings per share	$	14.59	$	13.93
	Diluted earnings per share	$	14.5	$	13.81
	Potentially dilutive securities representing 0.4 million and 3.7 million shares of common stock for the three months ended December 28, 2013 and December 29, 2012, respectively, were excluded from the computation of diluted earnings per common share because their effect would have been antidilutive.

Financial_Instruments

Financial Instruments	3 Months Ended
	Dec. 28, 2013
Financial Instruments	'
	Note 2 – Financial Instruments
	Cash, Cash Equivalents and Marketable Securities
	The following tables show the Company’s cash and available-for-sale securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of December 28, 2013 and September 28, 2013 (in millions):
			December 28, 2013
			Adjusted		Unrealized		Unrealized			Fair			Cash and				Short-Term				Long-Term
			Cost		Gains		Losses			Value			Cash				Marketable				Marketable
													Equivalents				Securities				Securities
	Cash		$	8,404	$	0	$	0		$	8,404		$	8,404			$	0			$	0
	Level 1 (a):
	Money market funds			2,236		0		0			2,236			2,236				0				0
	Mutual funds			4,045		0		(248	)		3,797			0				3,797				0
	Subtotal			6,281		0		(248	)		6,033			2,236				3,797				0
	Level 2 (b):
	U.S. Treasury securities			39,177		11		(62	)		39,126			629				8,498				29,999
	U.S. agency securities			16,087		7		(37	)		16,057			1,016				3,854				11,187
	Non-U.S. government securities			5,470		25		(141	)		5,354			0				276				5,078
	Certificates of deposit and time deposits			1,438		0		0			1,438			668				494				276
	Commercial paper			2,212		0		0			2,212			1,122				991				99
	Corporate securities			57,709		297		(221	)		57,785			2				7,658				50,125
	Municipal securities			6,246		49		(13	)		6,282			0				1,021				5,261
	Mortgage- and asset-backed securities			16,221		23		(93	)		16,151			0				45				16,106
	Subtotal			144,560		412		(567	)		144,405			3,437				22,837				118,131
	Total		$	159,245	$	412	$	(815	)	$	158,842		$	14,077			$	26,634			$	118,131
			September 28, 2013
			Adjusted		Unrealized		Unrealized			Fair			Cash and				Short-Term				Long-Term
			Cost		Gains		Losses			Value			Cash				Marketable				Marketable
													Equivalents				Securities				Securities
	Cash		$	8,705	$	0	$	0		$	8,705		$	8,705			$	0			$	0
	Level 1 (a):
	Money market funds			1,793		0		0			1,793			1,793				0				0
	Mutual funds			3,999		0		(197	)		3,802			0				3,802				0
	Subtotal			5,792		0		(197	)		5,595			1,793				3,802				0
	Level 2 (b):
	U.S. Treasury securities			27,642		24		(47	)		27,619			431				7,554				19,634
	U.S. agency securities			16,878		12		(52	)		16,838			177				3,412				13,249
	Non-U.S. government securities			5,545		35		(137	)		5,443			50				313				5,080
	Certificates of deposit and time deposits			2,344		0		0			2,344			1,264				844				236
	Commercial paper			2,998		0		0			2,998			1,835				1,163				0
	Corporate securities			54,586		275		(252	)		54,609			0				8,077				46,532
	Municipal securities			6,257		45		(22	)		6,280			4				1,114				5,162
	Mortgage- and asset-backed securities			16,396		23		(89	)		16,330			0				8				16,322
	Subtotal			132,646		414		(599	)		132,461			3,761				22,485				106,215
	Total		$	147,143	$	414	$	(796	)	$	146,761		$	14,259			$	26,287			$	106,215
	(a)	The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.
	(b)	The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The net realized gains or losses recognized by the Company related to such sales were not significant during the three months ended December 28, 2013 and December 29, 2012. The maturities of the Company’s long-term marketable securities generally range from one to five years.
	As of December 28, 2013 and September 28, 2013, gross unrealized losses related to individual securities that had been in a continuous loss position for 12 months or longer were not significant.
	As of December 28, 2013, the Company considers the declines in market value of its marketable securities investment portfolio to be temporary in nature and does not consider any of its investments other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy requires investments generally to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates, and the Company’s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment’s cost basis. During the three months ended December 28, 2013 and December 29, 2012, the Company did not recognize any significant impairment charges.
	Derivative Financial Instruments
	The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate risk. The Company may enter into forward contracts, option contracts, swaps, or other derivative instruments to offset some of the risk on expected future cash flows, on net investments in certain foreign subsidiaries, and on certain existing assets and liabilities.
	To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company’s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries’ functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.
	To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates.
	To help protect against adverse fluctuations in interest rates, the Company may enter into interest rate swaps, options, or other instruments to offset a portion of the changes in income or expense due to fluctuations in interest rates.
	The Company may also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates.
	The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company’s accounting treatment for these instruments is based on whether the instruments are designated as hedge or non-hedge instruments. The effective portions of cash flow hedges are recorded in AOCI until the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in other comprehensive income (“OCI”) as a part of the cumulative translation adjustment. The ineffective portions of cash flow hedges and net investment hedges are recorded in other income and expense. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates.
	Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized as a component of other income/(expense), net in the same period as the related income or expense is recognized. The Company’s hedged foreign currency transactions and hedged interest rate transactions as of December 28, 2013 are expected to occur within 12 months and five years, respectively.
	Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income and expense. Any subsequent changes in fair value of such derivative instruments are reflected in other income and expense unless they are re-designated as hedges of other transactions. The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three months ended December 28, 2013 and December 29, 2012.
	The Company’s unrealized net gains and losses on net investment hedges, included in the cumulative translation adjustment account of AOCI, were not significant as of December 28, 2013 and September 28, 2013. The ineffective portions and amounts excluded from the effectiveness test of net investment hedges are recorded in other income and expense.
	The gain/loss recognized in other income and expense for foreign currency forward and option contracts not designated as hedging instruments was not significant during the three months ended December 28, 2013 and December 29, 2012.
	The following table shows the notional principal amounts of the Company’s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of December 28, 2013 and September 28, 2013 (in millions):
			December 28, 2013				September 28, 2013
			Notional		Credit Risk		Notional			Credit Risk
			Principal		Amounts		Principal			Amounts
Instruments designated as accounting hedges:
Foreign exchange contracts		$	23,553	$	331	$	35,013		$	159
Interest rate contracts		$	3,000	$	55	$	3,000		$	44
Instruments not designated as accounting hedges:
Foreign exchange contracts		$	16,859	$	48	$	16,131		$	25
The notional principal amounts for outstanding derivative instruments provide one measure of the transaction volume outstanding and do not represent the amount of the Company’s exposure to credit or market loss. The credit risk amounts represent the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency or interest rates at each respective date. The Company’s gross exposure on these transactions may be further mitigated by collateral received from certain counterparties. The Company’s exposure to credit loss and market risk will vary over time as currency and interest rates change. Although the table above reflects the notional principal and credit risk amounts of the Company’s derivative instruments, it does not reflect the gains or losses associated with the exposures and transactions that the instruments are intended to hedge. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.
The Company generally enters into master netting arrangements, which are designed to reduce credit risk by permitting net settlement of transactions with the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values. As of December 28, 2013, the Company received $165 million of cash collateral related to the derivative instruments under its collateral security arrangements, which were recorded as accrued expenses in the Condensed Consolidated Balance Sheet. As of September 28, 2013, the Company posted cash collateral related to the derivative instruments under its collateral security arrangements of $164 million, which it recorded as other current assets in the Condensed Consolidated Balance Sheet. The Company did not have any derivative instruments with credit-risk related contingent features that would require it to post additional collateral as of December 28, 2013 or September 28, 2013.
Under master netting arrangements with the respective counterparties to the Company’s derivative contracts, the Company is allowed to net settle transactions with a single net amount payable by one party to the other. However, the Company has elected to present the derivative assets and derivative liabilities on a gross basis in its Condensed Consolidated Balance Sheets. As of December 28, 2013 and September 28, 2013, the potential effects of these rights of set-off associated with the Company’s derivative contracts, including the effects of collateral, would be a reduction to both derivative assets and derivative liabilities of $356 million and $333 million, respectively, resulting in net derivative liabilities of $66 million and $57 million, respectively.
The following tables show the Company’s derivative instruments at gross fair value as reflected in the Condensed Consolidated Balance Sheets as of December 28, 2013 and September 28, 2013 (in millions):
		December 28, 2013
		Fair Value of		Fair Value of		Total
		Derivatives		Derivatives		Fair
		Designated		Not Designated		Value
		as Hedge		as Hedge
		Instruments		Instruments
Derivative assets (a):
Foreign exchange contracts		$	263	$	48	$	311
Interest rate contracts		$	55	$	0	$	55
Derivative liabilities (b):
Foreign exchange contracts		$	231	$	36	$	267
		September 28, 2013
		Fair Value of		Fair Value of		Total
		Derivatives		Derivatives		Fair
		Designated		Not Designated		Value
		as Hedge		as Hedge
		Instruments		Instruments
Derivative assets (a):
Foreign exchange contracts		$	145	$	25	$	170
Interest rate contracts		$	44	$	0	$	44
Derivative liabilities (b):
Foreign exchange contracts		$	389	$	46	$	435
(a)	The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance Sheets.
(b)	The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance Sheets.
The following table shows the pre-tax effect of the Company’s derivative instruments designated as cash flow and net investment hedges in the Condensed Consolidated Statements of Operations for the three months ended December 28, 2013 and December 29, 2012 (in millions):
		Three Months Ended
		Gains/(Losses)				Gains/(Losses)						Gains/(Losses) Recognized - Ineffective
		Recognized in OCI -				Reclassified  from AOCI						Portion and Amount Excluded from
		Effective Portion				into Net Income -						Effectiveness Testing
						Effective Portion
		December 28,		December 29,		December 28,			December 29,			Financial Statement		December 28,				December 29,
		2013		2012		2013			2012			Line Item		2013				2012
Cash flow hedges:
Foreign exchange contracts		$	264	$	205	$	(74	)	$	(159	)	Other income/(expense), net		$	(3	)		$	9
Interest rate contracts			21		0		(4	)		0		Other income/(expense), net			0				0
Net investment hedges:
Foreign exchange contracts			24		36		0			0		Other income/(expense), net			1				0
Total		$	309	$	241	$	(78	)	$	(159	)			$	(2	)		$	9
Accounts Receivable
The Company has considerable trade receivables outstanding with its third-party cellular network carriers, wholesalers, retailers, value-added resellers, small and mid-sized businesses, and education, enterprise and government customers that are not covered by collateral, third-party financing arrangements or credit insurance. There were no customers that accounted for 10% or more of the Company’s trade receivables as of December 28, 2013. As of September 28, 2013, the Company had two customers that represented 10% or more of total trade receivables, one of which accounted for 13% and the other 10%. The Company’s cellular network carriers accounted for 48% and 68% of trade receivables as of December 28, 2013 and September 28, 2013, respectively.
Additionally, the Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these manufacturing vendors who manufacture sub-assemblies or assemble final products for the Company. Vendor non-trade receivables from two of the Company’s vendors accounted for 62% and 15% of total non-trade receivables as of December 28, 2013 and three of the Company’s vendors accounted for 47%, 21% and 15% of total non-trade receivables as of September 28, 2013.

Condensed_Consolidated_Financi

Condensed Consolidated Financial Statement Details	3 Months Ended
	Dec. 28, 2013
Condensed Consolidated Financial Statement Details	'
	Note 3 – Condensed Consolidated Financial Statement Details
	The following tables show the Company’s condensed consolidated financial statement details as of December 28, 2013 and September 28, 2013 (in millions):
	Inventories
		December 28, 2013			September 28, 2013
	Components	$	523		$	683
	Finished goods		1,599			1,081
	Total inventories	$	2,122		$	1,764
	Property, Plant and Equipment
		December 28, 2013			September 28, 2013
	Land and buildings	$	3,625		$	3,309
	Machinery, equipment and internal-use software		21,537			21,242
	Leasehold improvements		4,126			3,968
	Gross property, plant and equipment		29,288			28,519
	Accumulated depreciation and amortization		(13,800	)		(11,922	)
	Net property, plant and equipment	$	15,488		$	16,597
	Accrued Expenses
		December 28, 2013			September 28, 2013
	Accrued warranty and related costs	$	3,980		$	2,967
	Accrued taxes		2,083			1,200
	Deferred margin on component sales		1,475			1,262
	Accrued marketing and selling expenses		1,143			1,291
	Accrued compensation and employee benefits		1,002			959
	Other current liabilities		6,141			6,177
	Total accrued expenses	$	15,824		$	13,856
	Non-Current Liabilities
		December 28, 2013			September 28, 2013
	Deferred tax liabilities	$	18,306		$	16,489
	Other non-current liabilities		3,393			3,719
	Total other non-current liabilities	$	21,699		$	20,208
	Other Income and Expense
	The following table shows the detail of other income and expense for the three months ended December 28, 2013 and December 29, 2012 (in millions):
		Three Months Ended
		December 28, 2013			December 29, 2012
	Interest and dividend income	$	427		$	421
	Interest expense		(84	)		0
	Other expense, net		(97	)		41
	Total other income/(expense), net	$	246		$	462

Goodwill_and_Other_Intangible_

Goodwill and Other Intangible Assets	3 Months Ended
	Dec. 28, 2013
Goodwill and Other Intangible Assets	'
	Note 4 – Goodwill and Other Intangible Assets
	The Company’s acquired intangible assets with definite useful lives primarily consist of patents and licenses and are amortized over periods typically from three to seven years. The following table summarizes the components of gross and net intangible asset balances as of December 28, 2013 and September 28, 2013 (in millions):
		December 28, 2013							September 28, 2013
		Gross		Accumulated			Net		Gross		Accumulated			Net
		Carrying		Amortization			Carrying		Carrying		Amortization			Carrying
		Amount					Amount		Amount					Amount
	Definite lived and amortizable acquired intangible assets	$	6,271	$	(2,266	)	$	4,005	$	6,081	$	(2,002	)	$	4,079
	Indefinite lived and non-amortizable acquired intangible assets		100		0			100		100		0			100
	Total acquired intangible assets	$	6,371	$	(2,266	)	$	4,105	$	6,181	$	(2,002	)	$	4,179
	During the first quarter of 2014, the Company completed various business acquisitions. The aggregate cash consideration paid, net of cash acquired, was $525 million, of which $440 million was allocated to goodwill, $156 million to acquired intangible assets and $71 million to net liabilities assumed.

Income_Taxes

Income Taxes	3 Months Ended
	Dec. 28, 2013
Income Taxes	'
	Note 5 – Income Taxes
	As of December 28, 2013, the Company recorded gross unrecognized tax benefits of $3.0 billion, of which $1.5 billion, if recognized, would affect the Company’s effective tax rate. As of September 28, 2013, the total amount of gross unrecognized tax benefits was $2.7 billion, of which $1.4 billion, if recognized, would affect the Company’s effective tax rate. The Company’s total gross unrecognized tax benefits are classified as other non-current liabilities in the Condensed Consolidated Balance Sheets. The Company had $643 million and $590 million of gross interest and penalties accrued as of December 28, 2013 and September 28, 2013, respectively, which are classified as other non-current liabilities in the Condensed Consolidated Balance Sheets.
	Management believes that an adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If any issues addressed in the Company’s tax audits are resolved in a manner not consistent with management’s expectations, the Company could be required to adjust its provision for income tax in the period such resolution occurs. Although timing of the resolution and/or closure of audits is not certain, the Company believes it is reasonably possible that tax audit resolutions could reduce its unrecognized tax benefits by between $140 million and $160 million in the next 12 months.

LongTerm_Debt

Long-Term Debt	3 Months Ended
	Dec. 28, 2013
Long-Term Debt	'
	Note 6 – Long-Term Debt
	In May 2013, the Company issued floating- and fixed-rate notes with varying maturities for an aggregate principal amount of $17.0 billion (collectively the “Notes”). The Notes are senior unsecured obligations, and interest is payable in arrears, quarterly for the floating-rate notes and semi-annually for the fixed-rate notes.
	The principal amounts and associated effective interest rates of the Notes as of December 28, 2013, are as follows:
		Amount		Effective
		(in millions)		Interest
				Rate
	Floating-rate notes, due 2016	$	1,000		0.51%
	Floating-rate notes, due 2018		2,000		1.10%
	Fixed-rate 0.45% notes due 2016		1,500		0.51%
	Fixed-rate 1.00% notes due 2018		4,000		1.08%
	Fixed-rate 2.40% notes due 2023		5,500		2.44%
	Fixed-rate 3.85% notes due 2043		3,000		3.91%
	Total	$	17,000
	The floating-rate notes due 2016 and 2018 bear interest at the three-month London InterBank Offered Rate (“LIBOR”) plus 0.05% and 0.25%, respectively. To manage the risk of fluctuations in interest rates associated with the floating-rate notes, the Company entered into interest rate swaps with an aggregate notional amount of $3.0 billion designated as cash flow hedges of its floating-rate notes. These hedges effectively convert the floating interest rate on the floating-rate notes to a fixed interest rate. The gains and losses related to changes in the fair value of the interest rate swaps are recorded in OCI with a portion reclassified to interest expense each period to offset changes in interest rates on the floating-rate notes. The effective rates for the Notes include the interest on the Notes, amortization of the discount and, if applicable, adjustments related to hedging. The Company recognized $84 million of interest expense for the three months ended December 28, 2013. As of December 28, 2013, the aggregate unamortized discount for the Company’s Notes was $39 million.
	Future principal payments for the Company’s Notes as of December 28, 2013, are as follows (in millions):
	2014	$	0
	2015		0
	2016		2,500
	2017		0
	2018		6,000
	Thereafter		8,500
	Total	$	17,000
	As of December 28, 2013, the fair value of the Company’s Notes, based on Level 2 inputs, was $15.8 billion.

Shareholders_Equity

Shareholders' Equity	3 Months Ended
	Dec. 28, 2013
Shareholders' Equity	'
	Note 7 – Shareholders’ Equity
	Preferred Stock
	The Company has five million shares of authorized preferred stock, none of which is issued or outstanding. Under the terms of the Company’s Restated Articles of Incorporation, the Board of Directors is authorized to determine or alter the rights, preferences, privileges and restrictions of the Company’s authorized but unissued shares of preferred stock.
	Dividend and Share Repurchase Program
	The Company declared and paid cash dividends per common share during the periods presented as follows:
		Dividends		Amount
		Per Share		(in  millions)
	2014:00:00
	First quarter	$	3.05	$	2,739
	2013:00:00
	Fourth quarter	$	3.05	$	2,763
	Third quarter		3.05		2,789
	Second quarter		2.65		2,490
	First quarter		2.65		2,486
		$	11.4	$	10,528
	Future dividends are subject to declaration by the Board of Directors.
	In 2012, the Company’s Board of Directors authorized a program to repurchase up to $10 billion of the Company’s common stock beginning in 2013. In April 2013, the Company’s Board of Directors increased the share repurchase program authorization from $10 billion to $60 billion, of which $28.0 billion had been utilized as of December 28, 2013. The Company’s share repurchase program does not obligate it to acquire any specific number of shares. Under the program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
	In August 2012, the Company entered into an accelerated share repurchase arrangement (“ASR”) with a financial institution to purchase up to $1.95 billion of the Company’s common stock in 2013. In the first quarter of 2013, 2.6 million shares were initially delivered to the Company. In April 2013, the purchase period for the ASR ended and an additional 1.5 million shares were delivered to the Company. In total, 4.1 million shares were delivered under the ASR at an average repurchase price of $478.20 per share. The shares were retired in the quarters they were delivered, and the up-front payment of $1.95 billion was accounted for as a reduction to shareholders’ equity in the Company’s Condensed Consolidated Balance Sheet in the first quarter of 2013.
	In April 2013, the Company entered into a new ASR program with two financial institutions to purchase up to $12 billion of the Company’s common stock. In exchange for up-front payments totaling $12 billion, the financial institutions committed to deliver shares during the ASR’s purchase periods, which will end during 2014. The total number of shares ultimately delivered, and therefore the average price paid per share, will be determined at the end of the applicable purchase period based on the volume weighted-average price of the Company’s stock during that period. During the third quarter of 2013, 23.5 million shares were initially delivered to the Company and retired. This does not represent the final number of shares to be delivered under the ASR. The up-front payments of $12 billion were accounted for as a reduction to shareholders’ equity in the Company’s Condensed Consolidated Balance Sheet.
	The Company reflected the ASRs as a repurchase of common stock for purposes of calculating earnings per share and as forward contracts indexed to its own common stock. The forward contracts met all of the applicable criteria for equity classification, and, therefore, were not accounted for as derivative instruments.
	During the three months ended December 28, 2013, the Company repurchased 9.5 million shares of its common stock in the open market at an average price of $523.51 per share for a total of $5.0 billion. These shares were retired upon repurchase.

Comprehensive_Income

Comprehensive Income	3 Months Ended
	Dec. 28, 2013
Comprehensive Income	'
	Note 8 – Comprehensive Income
	Comprehensive income consists of two components, net income and other comprehensive income. Other comprehensive income refers to revenue, expenses, and gains and losses that under GAAP are recorded as an element of shareholders’ equity but are excluded from net income. The Company’s other comprehensive income consists of foreign currency translation adjustments from those subsidiaries not using the U.S. dollar as their functional currency, net deferred gains and losses on certain derivative instruments accounted for as cash flow hedges, and unrealized gains and losses on marketable securities classified as available-for-sale.
	The following table shows the gross amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations and the associated financial statement line item, for the three months ended December 28, 2013:
	Comprehensive Income Components	Financial Statement Line Item		Amount
				(in  millions)
	Unrecognized gains/losses on derivative instruments:
	Foreign exchange contracts	Revenue		$	184
		Cost of Sales			(110	)
		Other income/expense, net			10
	Interest rate contracts	Other income/expense, net			4
					88
	Unrealized gains/losses on marketable securities	Other income/expense, net			(17	)
	Total amounts reclassified from AOCI			$	71
	The following table shows the changes in AOCI by component for the three months ended December 28, 2013 (in millions):
		Cumulative				Unrecognized			Unrealized			Total
		Foreign				Gains/Losses			Gains/Losses
		Currency				on Derivative			on Marketable
		Translation				Instruments			Securities
	September 28, 2013	$	(105	)		$	(175	)	$	(191	)	$	(471	)
	Other comprehensive income/(loss) before reclassifications		(90	)			261			(68	)		103
	Amounts reclassified from AOCI		0				88			(17	)		71
	Tax effect		23				(64	)		32			(9	)
	Other comprehensive income/(loss)		(67	)			285			(53	)		165
	December 28, 2013	$	(172	)		$	110		$	(244	)	$	(306	)

Benefit_Plans

Benefit Plans	3 Months Ended
	Dec. 28, 2013
Benefit Plans	'
	Note 9 – Benefit Plans
	Restricted Stock Units
	A summary of the Company’s RSU activity and related information for the three months ended December 28, 2013, is as follows:
		Number of			Weighted-		Aggregate
		RSUs			Average		Intrinsic
		(in thousands)			Grant Date		Value
					Fair Value		(in millions)
	Balance at September 28, 2013		13,326		$	435.7
	RSUs granted		6,183		$	491.93
	RSUs vested		(2,256	)	$	379.23
	RSUs cancelled		(216	)	$	461.35
	Balance at December 28, 2013		17,037		$	463.23	$	9,543
	RSUs that vested during the three months ended December 28, 2013 and December 29, 2012 had a fair value of $1.1 billion and $1.5 billion, respectively, as of the vesting date.
	Stock Options
	A summary of the Company’s stock option activity and related information for the three months ended December 28, 2013, is as follows:
		Outstanding Options
		Number			Weighted-		Weighted-		Aggregate
		of Options			Average		Average		Intrinsic
		(in thousands)			Exercise		Remaining		Value
					Price		Contractual		(in millions)
							Term
							(in years)
	Balance at September 28, 2013		4,094		$	139.65
	Options granted		1		$	66.26
	Options exercised		(1,308	)	$	102.86
	Balance at December 28, 2013		2,787		$	156.89		1.2	$	1,124
	Exercisable at December 28, 2013		2,768		$	157.56		1.1	$	1,114
	Expected to vest after December 28, 2013		19		$	58.03		7.6	$	10
	Aggregate intrinsic value represents the value of the Company’s closing stock price on the last trading day of the period in excess of the weighted-average exercise price multiplied by the number of options outstanding or exercisable. The total intrinsic value of options at the time of exercise was $559 million and $347 million for the three-months ended December 28, 2013 and December 29, 2012, respectively.
	The Company had approximately 16.6 million shares reserved for future issuance under the Company’s stock plans as of December 28, 2013. RSUs granted reduce the number of shares available for grant under the Company’s stock plans utilizing a factor of two times the number of RSUs granted. Similarly, RSUs cancelled increase the number of shares available for grant under the Company’s stock plans utilizing a factor of two times the number of RSUs cancelled. Stock options count against the number of shares available for grant on a one-for-one basis.
	Share-based Compensation
	Share-based compensation cost for RSUs is measured based on the closing fair market value of the Company’s common stock on the date of grant. Share-based compensation cost for stock options and employee stock purchase plan rights (“stock purchase rights”) is measured at the grant date and offering date, respectively, based on the fair-value as calculated by the Black-Scholes-Merton (“BSM”) option-pricing model. The BSM option-pricing model incorporates various assumptions including expected volatility, estimated expected life and interest rates. The Company recognizes share-based compensation cost over the award’s requisite service period on a straight-line basis for time-based RSUs and on a graded basis for RSUs that are contingent on the achievement of performance metrics.
	The weighted-average fair value per stock option granted during the three months ended December 28, 2013 was $333.26. The Company did not grant any stock options during the three months ended December 29, 2012. The weighted-average fair value of stock purchase rights per share was $103.99 and $136.84 during the three months ended December 28, 2013 and December 29, 2012, respectively.
	In conjunction with certain business combinations, the Company assumed 29,000 stock options with a weighted-average fair value per share of $407.80 during the three months ended December 29, 2012. The Company did not assume any stock options during the three months ended December 28, 2013.
	The following table shows a summary of the share-based compensation expense included in the Condensed Consolidated Statements of Operations for the three months ended December 28, 2013 and December 29, 2012 (in millions):
		Three Months Ended
		December 28,			December 29,
		2013			2012
	Cost of sales	$	109		$	85
	Research and development		289			224
	Selling, general and administrative		283			236
	Total share-based compensation expense	$	681		$	545
	The income tax benefit related to share-based compensation expense was $265 million and $214 million for the three months ended December 28, 2013 and December 29, 2012, respectively. As of December 28, 2013, the total unrecognized compensation cost related to outstanding stock options and RSUs expected to vest was $6.6 billion, which the Company expects to recognize over a weighted-average period of 3.2 years.
	Stock Plans
	Rule 10b5-1 Trading Plans
	During the three months ended December 28, 2013, executive officers Timothy D. Cook, Peter Oppenheimer, D. Bruce Sewell, Philip W. Schiller, Daniel Riccio and Jeffrey E. Williams had equity trading plans in place in accordance with Rule 10b5-1(c)(1) under the Exchange Act. An equity trading plan is a written document that pre-establishes the amounts, prices and dates (or formula for determining the amounts, prices and dates) of future purchases or sales of the Company’s stock, including shares acquired pursuant to the Company’s employee and director equity plans.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Dec. 28, 2013
Commitments and Contingencies	'
	Note 10 – Commitments and Contingencies
	Accrued Warranty and Indemnification
	The following table shows changes in the Company’s accrued warranties and related costs for the three months ended December 28, 2013 and December 29, 2012 (in millions):
		Three Months Ended
		December 28,			December 29,
		2013			2012
	Beginning accrued warranty and related costs	$	2,967		$	1,638
	Cost of warranty claims		(1,064	)		(686	)
	Accruals for product warranty		2,077			1,358
	Ending accrued warranty and related costs	$	3,980		$	2,310
	The Company generally does not indemnify end-users of its operating system and application software against legal claims that the software infringes third-party intellectual property rights. Other agreements entered into by the Company sometimes include indemnification provisions under which the Company could be subject to costs and/or damages in the event of an infringement claim against the Company or an indemnified third-party. However, the Company has not been required to make any significant payments resulting from such an infringement claim asserted against it or an indemnified third-party and, in the opinion of management, does not have a potential liability related to unresolved infringement claims subject to indemnification that would materially adversely affect its financial condition or operating results. Therefore, the Company did not record a liability for infringement costs related to indemnification as of either December 28, 2013 or September 28, 2013.
	The Company has entered into indemnification agreements with its directors and executive officers. Under these agreements, the Company has agreed to indemnify such individuals to the fullest extent permitted by law against liabilities that arise by reason of their status as directors or officers and to advance expenses incurred by such individuals in connection with related legal proceedings. It is not possible to determine the maximum potential amount of payments the Company could be required to make under these agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each claim. However, the Company maintains directors and officers liability insurance coverage to reduce its exposure to such obligations, and payments made under these agreements historically have not been material.
	Concentrations in the Available Sources of Supply of Materials and Product
	Although most components essential to the Company’s business are generally available from multiple sources, a number of components are currently obtained from single or limited sources. In addition, the Company competes for various components with other participants in the markets for mobile communication and media devices and personal computers. Therefore, many components used by the Company, including those that are available from multiple sources, are at times subject to industry-wide shortage and significant pricing fluctuations that can materially adversely affect the Company’s financial condition and operating results.
	The Company uses some custom components that are not commonly used by its competitors, and new products introduced by the Company often utilize custom components available from only one source. When a component or product uses new technologies, initial capacity constraints may exist until the suppliers’ yields have matured or manufacturing capacity has increased. If the Company’s supply of components for a new or existing product were delayed or constrained, or if an outsourcing partner delayed shipments of completed products to the Company, the Company’s financial condition and operating results could be materially adversely affected. The Company’s business and financial performance could also be materially adversely affected depending on the time required to obtain sufficient quantities from the original source, or to identify and obtain sufficient quantities from an alternative source. Continued availability of these components at acceptable prices, or at all, may be affected if those suppliers concentrated on the production of common components instead of components customized to meet the Company’s requirements.
	The Company has entered into various agreements for the supply of components; however, there can be no guarantee that the Company will be able to extend or renew these agreements on similar terms, or at all. Therefore, the Company remains subject to significant risks of supply shortages and price increases that can materially adversely affect its financial condition and operating results.
	Substantially all of the Company’s hardware products are manufactured by outsourcing partners that are located primarily in Asia. A significant concentration of this manufacturing is currently performed by a small number of outsourcing partners, often in single locations. Certain of these outsourcing partners are the sole-sourced suppliers of components and manufacturers for many of the Company’s products. Although the Company works closely with its outsourcing partners on manufacturing schedules, the Company’s operating results could be adversely affected if its outsourcing partners were unable to meet their production commitments. The Company’s purchase commitments typically cover its requirements for periods up to 150 days.
	Other Off-Balance Sheet Commitments
	The Company leases various equipment and facilities, including retail space, under noncancelable operating lease arrangements. The Company does not currently utilize any other off-balance sheet financing arrangements. The major facility leases are typically for terms not exceeding 10 years and generally provide renewal options for terms not exceeding five additional years. Leases for retail space are for terms ranging from five to 20 years, the majority of which are for 10 years, and often contain multi-year renewal options. As of December 28, 2013, the Company’s total future minimum lease payments under noncancelable operating leases were $4.7 billion, of which $3.5 billion related to leases for retail space.
	The Company utilizes several outsourcing partners to manufacture sub-assemblies for the Company’s products and to perform final assembly and testing of finished products. These outsourcing partners acquire components and build product based on demand information supplied by the Company, which typically covers periods up to 150 days. The Company also obtains individual components for its products from a wide variety of individual suppliers. Consistent with industry practice, the Company acquires components through a combination of purchase orders, supplier contracts, and open orders based on projected demand information. Where appropriate, the purchases are applied to inventory component prepayments that are outstanding with the respective supplier. As of December 28, 2013, the Company had outstanding off-balance sheet third-party manufacturing commitments and component purchase commitments of $16.1 billion.
	In addition to the commitments mentioned above, the Company had additional off-balance sheet obligations of $1.5 billion as of December 28, 2013, which were comprised mainly of commitments to acquire capital assets, including product tooling and manufacturing process equipment, and commitments related to advertising, research and development, Internet and telecommunications services and other obligations.
	Contingencies
	The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully adjudicated, certain of which are discussed in Part II, Item 1 of this Form 10-Q under the heading “Legal Proceedings” and in Part II, Item 1A of this Form 10-Q under the heading “Risk Factors.” In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss in excess of a recorded accrual, with respect to loss contingencies. However, the outcome of litigation is inherently uncertain. Therefore, although management considers the likelihood of such an outcome to be remote, if one or more of these legal matters were resolved against the Company in a reporting period for amounts in excess of management’s expectations, the Company’s consolidated financial statements for that reporting period could be materially adversely affected.
	Apple Inc. v. Samsung Electronics Co., Ltd, et al.
	On August 24, 2012, a jury returned a verdict awarding the Company $1.05 billion in its lawsuit against Samsung Electronics Co., Ltd and affiliated parties in the United States District Court, Northern District of California, San Jose Division. The District Court upheld $640 million of the jury’s award and ordered a new trial as to the remainder. The retrial jury awarded an additional $290 million, bringing the total verdict to $930 million. Because the award is subject to entry of final judgment and appeal, the Company has not recognized the award in its results of operations.
	VirnetX, Inc. v. Apple Inc. et al.
	On August 11, 2010, VirnetX, Inc. filed an action against the Company alleging that certain of its products infringed on four patents relating to network communications technology. On November 6, 2012, a jury returned a verdict against the Company, and awarded damages of $368 million. The Company is challenging the verdict, believes it has valid defenses and has not recorded a loss accrual at this time.

Segment_Information_and_Geogra

Segment Information and Geographic Data	3 Months Ended
	Dec. 28, 2013
Segment Information and Geographic Data	'
	Note 11 – Segment Information and Geographic Data
	The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of the Company’s reportable segments.
	The Company manages its business primarily on a geographic basis. The Company’s reportable operating segments consist of the Americas, Europe, Greater China, Japan, Rest of Asia Pacific and Retail operations. The Americas segment includes both North and South America. The Europe segment includes European countries, as well as India, the Middle East and Africa. The Greater China segment includes China, Hong Kong and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries, other than those countries included in the Company’s other operating segments. The results of the Company’s geographic segments do not include results of the Retail segment. Each operating segment provides similar hardware and software products and similar services. The accounting policies of the various segments are the same as those described in Note 1, “Summary of Significant Accounting Policies” of the Notes to Consolidated Financial Statements in Part II, Item 8 of the Company’s 2013 Form 10-K.
	The Company evaluates the performance of its operating segments based on net sales and operating income. Net sales for geographic segments are generally based on the location of customers, while Retail segment net sales are based on sales through the Company’s retail stores. Operating income for each segment includes net sales to third parties, related cost of sales and operating expenses directly attributable to the segment. Advertising expenses are generally included in the geographic segment in which the expenditures are incurred. Operating income for each segment excludes other income and expense and certain expenses managed outside the operating segments. Costs excluded from segment operating income include various corporate expenses such as research and development, corporate marketing expenses, share-based compensation expense, income taxes, various nonrecurring charges, and other separately managed general and administrative costs and certain manufacturing period expenses. The Company does not include intercompany transfers between segments for management reporting purposes.
	The following table shows information by operating segment for the three months ended December 28, 2013 and December 29, 2012 (in millions):
		Three Months Ended
		December 28,			December 29,
		2013			2012
	Americas:
	Net sales	$	20,098		$	20,341
	Operating income	$	7,266		$	7,349
	Europe:
	Net sales	$	13,073		$	12,464
	Operating income	$	4,576		$	4,409
	Greater China:
	Net sales	$	8,844		$	6,830
	Operating income	$	3,140		$	2,544
	Japan:
	Net sales	$	4,948		$	4,443
	Operating income	$	2,379		$	2,260
	Rest of Asia Pacific:
	Net sales	$	3,633		$	3,993
	Operating income	$	1,329		$	1,335
	Retail:
	Net sales	$	6,998		$	6,441
	Operating income	$	1,744		$	1,557
	A reconciliation of the Company’s segment operating income to the condensed consolidated financial statements for the three months ended December 28, 2013 and December 29, 2012 is as follows (in millions):
		Three Months Ended
		December 28,			December 29,
		2013			2012
	Segment operating income	$	20,434		$	19,454
	Share-based compensation expense		(681	)		(545	)
	Other corporate expenses, net		(2,290	)		(1,699	)
	Total operating income	$	17,463		$	17,210

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Dec. 28, 2013
Basis of Presentation and Preparation	'
	Basis of Presentation and Preparation
	The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.
	These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and the notes thereto for the fiscal year ended September 28, 2013, included in its Annual Report on Form 10-K (the “2013 Form 10-K”). The Company’s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter approximately every six years to realign fiscal quarters with calendar quarters. The Company’s fiscal years 2014 and 2013 each include 52 weeks. Unless otherwise stated, references to particular years, quarters or months refer to the Company’s fiscal years ended in September and the associated quarters or months of those fiscal years.
	During the first quarter of 2014, the Company adopted updated accounting standards that (i) required disclosure of additional information about the amounts reclassified out of Accumulated Other Comprehensive Income (“AOCI”) by component and (ii) required gross and net disclosures about offsetting assets and liabilities. The adoption of these updated standards only impacted the disclosures in the Notes to the Condensed Consolidated Financial Statements; accordingly, the adoption had no impact on the Company’s financial position or results of operations. The Company has provided these additional disclosures in this Form 10-Q in Note 8, “Comprehensive Income” and Note 2, “Financial Instruments,” respectively.
Revenue Recognition	'
	Revenue Recognition
	In 2013, the Company’s combined best estimates of selling price (“ESPs”) for the unspecified software upgrade rights and the rights to receive the non-software services included with its qualifying hardware devices ranged from $5 to $25. Beginning in the first quarter of 2014, the Company adjusted the combined ESPs for Mac from $20 to $40 to reflect additions to unspecified software upgrade rights related to expansion of bundled essential software.
Earnings Per Share	'
	Earnings Per Share
	Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company’s employee stock purchase plan and unvested restricted stock units (“RSUs”). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s common stock can result in a greater dilutive effect from potentially dilutive securities.
	The following table shows the computation of basic and diluted earnings per share for the three months ended December 28, 2013 and December 29, 2012 (in thousands, except net income in millions and per share amounts):
		Three Months Ended
		December 28,		December 29,
		2013		2012
	Numerator:
	Net income	$	13,072	$	13,078
	Denominator:
	Weighted-average shares outstanding		896,072		938,916
	Effect of dilutive securities		5,380		8,301
	Weighted-average diluted shares		901,452		947,217
	Basic earnings per share	$	14.59	$	13.93
	Diluted earnings per share	$	14.5	$	13.81
	Potentially dilutive securities representing 0.4 million and 3.7 million shares of common stock for the three months ended December 28, 2013 and December 29, 2012, respectively, were excluded from the computation of diluted earnings per common share because their effect would have been antidilutive.
Derivative Financial Instruments	'
	Derivative Financial Instruments
	The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate risk. The Company may enter into forward contracts, option contracts, swaps, or other derivative instruments to offset some of the risk on expected future cash flows, on net investments in certain foreign subsidiaries, and on certain existing assets and liabilities.
	To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company’s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries’ functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.
	To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates.
	To help protect against adverse fluctuations in interest rates, the Company may enter into interest rate swaps, options, or other instruments to offset a portion of the changes in income or expense due to fluctuations in interest rates.
	The Company may also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates.
	The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company’s accounting treatment for these instruments is based on whether the instruments are designated as hedge or non-hedge instruments. The effective portions of cash flow hedges are recorded in AOCI until the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in other comprehensive income (“OCI”) as a part of the cumulative translation adjustment. The ineffective portions of cash flow hedges and net investment hedges are recorded in other income and expense. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates.
	Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized as a component of other income/(expense), net in the same period as the related income or expense is recognized. The Company’s hedged foreign currency transactions and hedged interest rate transactions as of December 28, 2013 are expected to occur within 12 months and five years, respectively.
	Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income and expense. Any subsequent changes in fair value of such derivative instruments are reflected in other income and expense unless they are re-designated as hedges of other transactions. The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three months ended December 28, 2013 and December 29, 2012.
	The Company’s unrealized net gains and losses on net investment hedges, included in the cumulative translation adjustment account of AOCI, were not significant as of December 28, 2013 and September 28, 2013. The ineffective portions and amounts excluded from the effectiveness test of net investment hedges are recorded in other income and expense.
	The gain/loss recognized in other income and expense for foreign currency forward and option contracts not designated as hedging instruments was not significant during the three months ended December 28, 2013 and December 29, 2012.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Dec. 28, 2013
Computation of Basic and Diluted Earnings Per Share	'
	The following table shows the computation of basic and diluted earnings per share for the three months ended December 28, 2013 and December 29, 2012 (in thousands, except net income in millions and per share amounts):
		Three Months Ended
		December 28,		December 29,
		2013		2012
	Numerator:
	Net income	$	13,072	$	13,078
	Denominator:
	Weighted-average shares outstanding		896,072		938,916
	Effect of dilutive securities		5,380		8,301
	Weighted-average diluted shares		901,452		947,217
	Basic earnings per share	$	14.59	$	13.93
	Diluted earnings per share	$	14.5	$	13.81

Financial_Instruments_Tables

Financial Instruments (Tables)	3 Months Ended
	Dec. 28, 2013
Cash and Available-for-Sale Securities' Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Marketable Securities	'
	The following tables show the Company’s cash and available-for-sale securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of December 28, 2013 and September 28, 2013 (in millions):
			December 28, 2013
			Adjusted		Unrealized		Unrealized			Fair			Cash and				Short-Term				Long-Term
			Cost		Gains		Losses			Value			Cash				Marketable				Marketable
													Equivalents				Securities				Securities
	Cash		$	8,404	$	0	$	0		$	8,404		$	8,404			$	0			$	0
	Level 1 (a):
	Money market funds			2,236		0		0			2,236			2,236				0				0
	Mutual funds			4,045		0		(248	)		3,797			0				3,797				0
	Subtotal			6,281		0		(248	)		6,033			2,236				3,797				0
	Level 2 (b):
	U.S. Treasury securities			39,177		11		(62	)		39,126			629				8,498				29,999
	U.S. agency securities			16,087		7		(37	)		16,057			1,016				3,854				11,187
	Non-U.S. government securities			5,470		25		(141	)		5,354			0				276				5,078
	Certificates of deposit and time deposits			1,438		0		0			1,438			668				494				276
	Commercial paper			2,212		0		0			2,212			1,122				991				99
	Corporate securities			57,709		297		(221	)		57,785			2				7,658				50,125
	Municipal securities			6,246		49		(13	)		6,282			0				1,021				5,261
	Mortgage- and asset-backed securities			16,221		23		(93	)		16,151			0				45				16,106
	Subtotal			144,560		412		(567	)		144,405			3,437				22,837				118,131
	Total		$	159,245	$	412	$	(815	)	$	158,842		$	14,077			$	26,634			$	118,131
			September 28, 2013
			Adjusted		Unrealized		Unrealized			Fair			Cash and				Short-Term				Long-Term
			Cost		Gains		Losses			Value			Cash				Marketable				Marketable
													Equivalents				Securities				Securities
	Cash		$	8,705	$	0	$	0		$	8,705		$	8,705			$	0			$	0
	Level 1 (a):
	Money market funds			1,793		0		0			1,793			1,793				0				0
	Mutual funds			3,999		0		(197	)		3,802			0				3,802				0
	Subtotal			5,792		0		(197	)		5,595			1,793				3,802				0
	Level 2 (b):
	U.S. Treasury securities			27,642		24		(47	)		27,619			431				7,554				19,634
	U.S. agency securities			16,878		12		(52	)		16,838			177				3,412				13,249
	Non-U.S. government securities			5,545		35		(137	)		5,443			50				313				5,080
	Certificates of deposit and time deposits			2,344		0		0			2,344			1,264				844				236
	Commercial paper			2,998		0		0			2,998			1,835				1,163				0
	Corporate securities			54,586		275		(252	)		54,609			0				8,077				46,532
	Municipal securities			6,257		45		(22	)		6,280			4				1,114				5,162
	Mortgage- and asset-backed securities			16,396		23		(89	)		16,330			0				8				16,322
	Subtotal			132,646		414		(599	)		132,461			3,761				22,485				106,215
	Total		$	147,143	$	414	$	(796	)	$	146,761		$	14,259			$	26,287			$	106,215
	(a)	The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.
	(b)	The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Notional Principal Amounts of Outstanding Derivative Instruments and Credit Risk Amounts Associated with Outstanding or Unsettled Derivative Instruments	'
	The following table shows the notional principal amounts of the Company’s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of December 28, 2013 and September 28, 2013 (in millions):
			December 28, 2013				September 28, 2013
			Notional		Credit Risk		Notional			Credit Risk
			Principal		Amounts		Principal			Amounts
	Instruments designated as accounting hedges:
	Foreign exchange contracts		$	23,553	$	331	$	35,013		$	159
	Interest rate contracts		$	3,000	$	55	$	3,000		$	44
	Instruments not designated as accounting hedges:
	Foreign exchange contracts		$	16,859	$	48	$	16,131		$	25
Derivative Instruments at Gross Fair Value as Reflected in Condensed Consolidated Balance Sheets	'
	The following tables show the Company’s derivative instruments at gross fair value as reflected in the Condensed Consolidated Balance Sheets as of December 28, 2013 and September 28, 2013 (in millions):
			December 28, 2013
			Fair Value of		Fair Value of		Total
			Derivatives		Derivatives		Fair
			Designated		Not Designated		Value
			as Hedge		as Hedge
			Instruments		Instruments
	Derivative assets (a):
	Foreign exchange contracts		$	263	$	48	$	311
	Interest rate contracts		$	55	$	0	$	55
	Derivative liabilities (b):
	Foreign exchange contracts		$	231	$	36	$	267
			September 28, 2013
			Fair Value of		Fair Value of		Total
			Derivatives		Derivatives		Fair
			Designated		Not Designated		Value
			as Hedge		as Hedge
			Instruments		Instruments
	Derivative assets (a):
	Foreign exchange contracts		$	145	$	25	$	170
	Interest rate contracts		$	44	$	0	$	44
	Derivative liabilities (b):
	Foreign exchange contracts		$	389	$	46	$	435
	(a)	The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance Sheets.
	(b)	The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance Sheets.
Pre-Tax Effect of Derivative Instruments Designated as Cash Flow and Net Investment Hedges	'
	The following table shows the pre-tax effect of the Company’s derivative instruments designated as cash flow and net investment hedges in the Condensed Consolidated Statements of Operations for the three months ended December 28, 2013 and December 29, 2012 (in millions):
			Three Months Ended
			Gains/(Losses)				Gains/(Losses)						Gains/(Losses) Recognized - Ineffective
			Recognized in OCI -				Reclassified  from AOCI						Portion and Amount Excluded from
			Effective Portion				into Net Income -						Effectiveness Testing
							Effective Portion
			December 28,		December 29,		December 28,			December 29,			Financial Statement		December 28,				December 29,
			2013		2012		2013			2012			Line Item		2013				2012
	Cash flow hedges:
	Foreign exchange contracts		$	264	$	205	$	(74	)	$	(159	)	Other income/(expense), net		$	(3	)		$	9
	Interest rate contracts			21		0		(4	)		0		Other income/(expense), net			0				0
	Net investment hedges:
	Foreign exchange contracts			24		36		0			0		Other income/(expense), net			1				0
	Total		$	309	$	241	$	(78	)	$	(159	)			$	(2	)		$	9

Condensed_Consolidated_Financi1

Condensed Consolidated Financial Statement Details (Tables)	3 Months Ended
	Dec. 28, 2013
Inventories	'
	Inventories
		December 28, 2013			September 28, 2013
	Components	$	523		$	683
	Finished goods		1,599			1,081
	Total inventories	$	2,122		$	1,764
Property, Plant and Equipment	'
	Property, Plant and Equipment
		December 28, 2013			September 28, 2013
	Land and buildings	$	3,625		$	3,309
	Machinery, equipment and internal-use software		21,537			21,242
	Leasehold improvements		4,126			3,968
	Gross property, plant and equipment		29,288			28,519
	Accumulated depreciation and amortization		(13,800	)		(11,922	)
	Net property, plant and equipment	$	15,488		$	16,597
Accrued Expenses	'
	Accrued Expenses
		December 28, 2013			September 28, 2013
	Accrued warranty and related costs	$	3,980		$	2,967
	Accrued taxes		2,083			1,200
	Deferred margin on component sales		1,475			1,262
	Accrued marketing and selling expenses		1,143			1,291
	Accrued compensation and employee benefits		1,002			959
	Other current liabilities		6,141			6,177
	Total accrued expenses	$	15,824		$	13,856
Non-Current Liabilities	'
	Non-Current Liabilities
		December 28, 2013			September 28, 2013
	Deferred tax liabilities	$	18,306		$	16,489
	Other non-current liabilities		3,393			3,719
	Total other non-current liabilities	$	21,699		$	20,208
Other Income and Expense	'
	Other Income and Expense
	The following table shows the detail of other income and expense for the three months ended December 28, 2013 and December 29, 2012 (in millions):
		Three Months Ended
		December 28, 2013			December 29, 2012
	Interest and dividend income	$	427		$	421
	Interest expense		(84	)		0
	Other expense, net		(97	)		41
	Total other income/(expense), net	$	246		$	462

Goodwill_and_Other_Intangible_1

Goodwill and Other Intangible Assets (Tables)	3 Months Ended
	Dec. 28, 2013
Components of Gross and Net Intangible Asset Balances	'
	The following table summarizes the components of gross and net intangible asset balances as of December 28, 2013 and September 28, 2013 (in millions):
		December 28, 2013							September 28, 2013
		Gross		Accumulated			Net		Gross		Accumulated			Net
		Carrying		Amortization			Carrying		Carrying		Amortization			Carrying
		Amount					Amount		Amount					Amount
	Definite lived and amortizable acquired intangible assets	$	6,271	$	(2,266	)	$	4,005	$	6,081	$	(2,002	)	$	4,079
	Indefinite lived and non-amortizable acquired intangible assets		100		0			100		100		0			100
	Total acquired intangible assets	$	6,371	$	(2,266	)	$	4,105	$	6,181	$	(2,002	)	$	4,179

LongTerm_Debt_Tables

Long-Term Debt (Tables)	3 Months Ended
	Dec. 28, 2013
Summary of Principal Amounts of Notes and Associated Effective Interest Rates	'
	The principal amounts and associated effective interest rates of the Notes as of December 28, 2013, are as follows:
		Amount		Effective
		(in millions)		Interest
				Rate
	Floating-rate notes, due 2016	$	1,000		0.51%
	Floating-rate notes, due 2018		2,000		1.10%
	Fixed-rate 0.45% notes due 2016		1,500		0.51%
	Fixed-rate 1.00% notes due 2018		4,000		1.08%
	Fixed-rate 2.40% notes due 2023		5,500		2.44%
	Fixed-rate 3.85% notes due 2043		3,000		3.91%
	Total	$	17,000
Future Principal Payments for Notes	'
	Future principal payments for the Company’s Notes as of December 28, 2013, are as follows (in millions):
	2014	$	0
	2015		0
	2016		2,500
	2017		0
	2018		6,000
	Thereafter		8,500
	Total	$	17,000

Shareholders_Equity_Tables

Shareholders' Equity (Tables)	3 Months Ended
	Dec. 28, 2013
Cash Dividends Declared and Paid Per Common Share	'
	The Company declared and paid cash dividends per common share during the periods presented as follows:
		Dividends		Amount
		Per Share		(in  millions)
	2014:00:00
	First quarter	$	3.05	$	2,739
	2013:00:00
	Fourth quarter	$	3.05	$	2,763
	Third quarter		3.05		2,789
	Second quarter		2.65		2,490
	First quarter		2.65		2,486
		$	11.4	$	10,528

Comprehensive_Income_Tables

Comprehensive Income (Tables)	3 Months Ended
	Dec. 28, 2013
Gross Amounts Reclassified from AOCI into Condensed Consolidated Statements of Operations	'
	The following table shows the gross amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations and the associated financial statement line item, for the three months ended December 28, 2013:
	Comprehensive Income Components	Financial Statement Line Item		Amount
				(in  millions)
	Unrecognized gains/losses on derivative instruments:
	Foreign exchange contracts	Revenue		$	184
		Cost of Sales			(110	)
		Other income/expense, net			10
	Interest rate contracts	Other income/expense, net			4
					88
	Unrealized gains/losses on marketable securities	Other income/expense, net			(17	)
	Total amounts reclassified from AOCI			$	71
Change in Accumulated Other Comprehensive Income by Component	'
	The following table shows the changes in AOCI by component for the three months ended December 28, 2013 (in millions):
		Cumulative				Unrecognized			Unrealized			Total
		Foreign				Gains/Losses			Gains/Losses
		Currency				on Derivative			on Marketable
		Translation				Instruments			Securities
	September 28, 2013	$	(105	)		$	(175	)	$	(191	)	$	(471	)
	Other comprehensive income/(loss) before reclassifications		(90	)			261			(68	)		103
	Amounts reclassified from AOCI		0				88			(17	)		71
	Tax effect		23				(64	)		32			(9	)
	Other comprehensive income/(loss)		(67	)			285			(53	)		165
	December 28, 2013	$	(172	)		$	110		$	(244	)	$	(306	)

Benefit_Plans_Tables

Benefit Plans (Tables)	3 Months Ended
	Dec. 28, 2013
Restricted Stock Activity	'
	A summary of the Company’s RSU activity and related information for the three months ended December 28, 2013, is as follows:
		Number of			Weighted-		Aggregate
		RSUs			Average		Intrinsic
		(in thousands)			Grant Date		Value
					Fair Value		(in millions)
	Balance at September 28, 2013		13,326		$	435.7
	RSUs granted		6,183		$	491.93
	RSUs vested		(2,256	)	$	379.23
	RSUs cancelled		(216	)	$	461.35
	Balance at December 28, 2013		17,037		$	463.23	$	9,543
Stock Option and Related Information	'
	A summary of the Company’s stock option activity and related information for the three months ended December 28, 2013, is as follows:
		Outstanding Options
		Number			Weighted-		Weighted-		Aggregate
		of Options			Average		Average		Intrinsic
		(in thousands)			Exercise		Remaining		Value
					Price		Contractual		(in millions)
							Term
							(in years)
	Balance at September 28, 2013		4,094		$	139.65
	Options granted		1		$	66.26
	Options exercised		(1,308	)	$	102.86
	Balance at December 28, 2013		2,787		$	156.89		1.2	$	1,124
	Exercisable at December 28, 2013		2,768		$	157.56		1.1	$	1,114
	Expected to vest after December 28, 2013		19		$	58.03		7.6	$	10
Summary of Share-Based Compensation Expense	'
	The following table shows a summary of the share-based compensation expense included in the Condensed Consolidated Statements of Operations for the three months ended December 28, 2013 and December 29, 2012 (in millions):
		Three Months Ended
		December 28,			December 29,
		2013			2012
	Cost of sales	$	109		$	85
	Research and development		289			224
	Selling, general and administrative		283			236
	Total share-based compensation expense	$	681		$	545

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	3 Months Ended
	Dec. 28, 2013
Changes in Accrued Warranties and Related Costs	'
	The following table shows changes in the Company’s accrued warranties and related costs for the three months ended December 28, 2013 and December 29, 2012 (in millions):
		Three Months Ended
		December 28,			December 29,
		2013			2012
	Beginning accrued warranty and related costs	$	2,967		$	1,638
	Cost of warranty claims		(1,064	)		(686	)
	Accruals for product warranty		2,077			1,358
	Ending accrued warranty and related costs	$	3,980		$	2,310

Segment_Information_and_Geogra1

Segment Information and Geographic Data (Tables)	3 Months Ended
	Dec. 28, 2013
Summary Information by Operating Segment	'
	The following table shows information by operating segment for the three months ended December 28, 2013 and December 29, 2012 (in millions):
		Three Months Ended
		December 28,			December 29,
		2013			2012
	Americas:
	Net sales	$	20,098		$	20,341
	Operating income	$	7,266		$	7,349
	Europe:
	Net sales	$	13,073		$	12,464
	Operating income	$	4,576		$	4,409
	Greater China:
	Net sales	$	8,844		$	6,830
	Operating income	$	3,140		$	2,544
	Japan:
	Net sales	$	4,948		$	4,443
	Operating income	$	2,379		$	2,260
	Rest of Asia Pacific:
	Net sales	$	3,633		$	3,993
	Operating income	$	1,329		$	1,335
	Retail:
	Net sales	$	6,998		$	6,441
	Operating income	$	1,744		$	1,557
Reconciliation of Segment Operating Income to Consolidated Financial Statements	'
	A reconciliation of the Company’s segment operating income to the condensed consolidated financial statements for the three months ended December 28, 2013 and December 29, 2012 is as follows (in millions):
		Three Months Ended
		December 28,			December 29,
		2013			2012
	Segment operating income	$	20,434		$	19,454
	Share-based compensation expense		(681	)		(545	)
	Other corporate expenses, net		(2,290	)		(1,699	)
	Total operating income	$	17,463		$	17,210

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)	3 Months Ended			12 Months Ended	3 Months Ended	12 Months Ended
Share data in Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012	Dec. 28, 2013	Sep. 28, 2013	Dec. 28, 2013	Sep. 28, 2013
			Minimum	Minimum	Maximum	Maximum
Significant Accounting Policies [Line Items]	'	'	'	'	'	'
Estimated selling price for software upgrade right and non-software services for qualifying hardware devices (USD/unit sold)	'	'	'	$5	'	$25
Adjusted Mac estimated selling price for software upgrade rights and non-software services	'	'	$20	'	$40	'
Potentially dilutive securities excluded from computation of diluted earnings per common share because their effect would have been antidilutive	0.4	3.7	'	'	'	'

Computation_of_Basic_and_Dilut

Computation of Basic and Diluted Earnings Per Share (Detail) (USD $)	3 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012
Numerator:	'	'
Net income	$13,072	$13,078
Denominator:	'	'
Weighted-average shares outstanding	896,072	938,916
Effect of dilutive securities	5,380	8,301
Weighted-average diluted shares	901,452	947,217
Basic earnings per share	$14.59	$13.93
Diluted earnings per share	$14.50	$13.81

Cash_and_AvailableforSale_Secu

Cash and Available-for-Sale Securities' Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Marketable Securities (Detail) (USD $)	Dec. 28, 2013		Sep. 28, 2013		Dec. 29, 2012	Sep. 29, 2012
In Millions, unless otherwise specified
Schedule of Available-for-sale Securities [Line Items]	'		'		'	'
Adjusted Cost	$159,245		$147,143		'	'
Unrealized Gains	412		414		'	'
Unrealized Losses	-815		-796		'	'
Fair Value	158,842		146,761		'	'
Cash and Cash Equivalents	14,077		14,259		16,154	10,746
Short-term marketable securities	26,634		26,287		'	'
Long-term marketable securities	118,131		106,215		'	'
Cash	'		'		'	'
Schedule of Available-for-sale Securities [Line Items]	'		'		'	'
Adjusted Cost	8,404		8,705		'	'
Unrealized Gains	0		0		'	'
Unrealized Losses	0		0		'	'
Fair Value	8,404		8,705		'	'
Cash and Cash Equivalents	8,404		8,705		'	'
Short-term marketable securities	0		0		'	'
Long-term marketable securities	0		0		'	'
Level 1	'		'		'	'
Schedule of Available-for-sale Securities [Line Items]	'		'		'	'
Adjusted Cost	6,281	[1]	5,792	[1]	'	'
Unrealized Gains	0	[1]	0	[1]	'	'
Unrealized Losses	-248	[1]	-197	[1]	'	'
Fair Value	6,033	[1]	5,595	[1]	'	'
Cash and Cash Equivalents	2,236	[1]	1,793	[1]	'	'
Short-term marketable securities	3,797	[1]	3,802	[1]	'	'
Long-term marketable securities	0	[1]	0	[1]	'	'
Level 1 | Money market funds	'		'		'	'
Schedule of Available-for-sale Securities [Line Items]	'		'		'	'
Adjusted Cost	2,236	[1]	1,793	[1]	'	'
Unrealized Gains	0	[1]	0	[1]	'	'
Unrealized Losses	0	[1]	0	[1]	'	'
Fair Value	2,236	[1]	1,793	[1]	'	'
Cash and Cash Equivalents	2,236	[1]	1,793	[1]	'	'
Short-term marketable securities	0	[1]	0	[1]	'	'
Long-term marketable securities	0	[1]	0	[1]	'	'
Level 1 | Mutual funds	'		'		'	'
Schedule of Available-for-sale Securities [Line Items]	'		'		'	'
Adjusted Cost	4,045	[1]	3,999	[1]	'	'
Unrealized Gains	0	[1]	0	[1]	'	'
Unrealized Losses	-248	[1]	-197	[1]	'	'
Fair Value	3,797	[1]	3,802	[1]	'	'
Cash and Cash Equivalents	0	[1]	0	[1]	'	'
Short-term marketable securities	3,797	[1]	3,802	[1]	'	'
Long-term marketable securities	0	[1]	0	[1]	'	'
Level 2	'		'		'	'
Schedule of Available-for-sale Securities [Line Items]	'		'		'	'
Adjusted Cost	144,560	[2]	132,646	[2]	'	'
Unrealized Gains	412	[2]	414	[2]	'	'
Unrealized Losses	-567	[2]	-599	[2]	'	'
Fair Value	144,405	[2]	132,461	[2]	'	'
Cash and Cash Equivalents	3,437	[2]	3,761	[2]	'	'
Short-term marketable securities	22,837	[2]	22,485	[2]	'	'
Long-term marketable securities	118,131	[2]	106,215	[2]	'	'
Level 2 | U.S. Treasury Securities	'		'		'	'
Schedule of Available-for-sale Securities [Line Items]	'		'		'	'
Adjusted Cost	39,177	[2]	27,642	[2]	'	'
Unrealized Gains	11	[2]	24	[2]	'	'
Unrealized Losses	-62	[2]	-47	[2]	'	'
Fair Value	39,126	[2]	27,619	[2]	'	'
Cash and Cash Equivalents	629	[2]	431	[2]	'	'
Short-term marketable securities	8,498	[2]	7,554	[2]	'	'
Long-term marketable securities	29,999	[2]	19,634	[2]	'	'
Level 2 | U.S. agency securities	'		'		'	'
Schedule of Available-for-sale Securities [Line Items]	'		'		'	'
Adjusted Cost	16,087	[2]	16,878	[2]	'	'
Unrealized Gains	7	[2]	12	[2]	'	'
Unrealized Losses	-37	[2]	-52	[2]	'	'
Fair Value	16,057	[2]	16,838	[2]	'	'
Cash and Cash Equivalents	1,016	[2]	177	[2]	'	'
Short-term marketable securities	3,854	[2]	3,412	[2]	'	'
Long-term marketable securities	11,187	[2]	13,249	[2]	'	'
Level 2 | Non-U.S. government securities	'		'		'	'
Schedule of Available-for-sale Securities [Line Items]	'		'		'	'
Adjusted Cost	5,470	[2]	5,545	[2]	'	'
Unrealized Gains	25	[2]	35	[2]	'	'
Unrealized Losses	-141	[2]	-137	[2]	'	'
Fair Value	5,354	[2]	5,443	[2]	'	'
Cash and Cash Equivalents	0	[2]	50	[2]	'	'
Short-term marketable securities	276	[2]	313	[2]	'	'
Long-term marketable securities	5,078	[2]	5,080	[2]	'	'
Level 2 | Certificates of deposit and time deposits	'		'		'	'
Schedule of Available-for-sale Securities [Line Items]	'		'		'	'
Adjusted Cost	1,438	[2]	2,344	[2]	'	'
Unrealized Gains	0	[2]	0	[2]	'	'
Unrealized Losses	0	[2]	0	[2]	'	'
Fair Value	1,438	[2]	2,344	[2]	'	'
Cash and Cash Equivalents	668	[2]	1,264	[2]	'	'
Short-term marketable securities	494	[2]	844	[2]	'	'
Long-term marketable securities	276	[2]	236	[2]	'	'
Level 2 | Commercial Paper	'		'		'	'
Schedule of Available-for-sale Securities [Line Items]	'		'		'	'
Adjusted Cost	2,212	[2]	2,998	[2]	'	'
Unrealized Gains	0	[2]	0	[2]	'	'
Unrealized Losses	0	[2]	0	[2]	'	'
Fair Value	2,212	[2]	2,998	[2]	'	'
Cash and Cash Equivalents	1,122	[2]	1,835	[2]	'	'
Short-term marketable securities	991	[2]	1,163	[2]	'	'
Long-term marketable securities	99	[2]	0	[2]	'	'
Level 2 | Corporate Securities	'		'		'	'
Schedule of Available-for-sale Securities [Line Items]	'		'		'	'
Adjusted Cost	57,709	[2]	54,586	[2]	'	'
Unrealized Gains	297	[2]	275	[2]	'	'
Unrealized Losses	-221	[2]	-252	[2]	'	'
Fair Value	57,785	[2]	54,609	[2]	'	'
Cash and Cash Equivalents	2	[2]	0	[2]	'	'
Short-term marketable securities	7,658	[2]	8,077	[2]	'	'
Long-term marketable securities	50,125	[2]	46,532	[2]	'	'
Level 2 | Municipal securities	'		'		'	'
Schedule of Available-for-sale Securities [Line Items]	'		'		'	'
Adjusted Cost	6,246	[2]	6,257	[2]	'	'
Unrealized Gains	49	[2]	45	[2]	'	'
Unrealized Losses	-13	[2]	-22	[2]	'	'
Fair Value	6,282	[2]	6,280	[2]	'	'
Cash and Cash Equivalents	0	[2]	4	[2]	'	'
Short-term marketable securities	1,021	[2]	1,114	[2]	'	'
Long-term marketable securities	5,261	[2]	5,162	[2]	'	'
Level 2 | Mortgage and asset-backed securities	'		'		'	'
Schedule of Available-for-sale Securities [Line Items]	'		'		'	'
Adjusted Cost	16,221	[2]	16,396	[2]	'	'
Unrealized Gains	23	[2]	23	[2]	'	'
Unrealized Losses	-93	[2]	-89	[2]	'	'
Fair Value	16,151	[2]	16,330	[2]	'	'
Cash and Cash Equivalents	0	[2]	0	[2]	'	'
Short-term marketable securities	45	[2]	8	[2]	'	'
Long-term marketable securities	$16,106	[2]	$16,322	[2]	'	'
[1]	The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.
[2]	The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Financial_Instruments_Addition

Financial Instruments - Additional Information (Detail) (USD $)	3 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Sep. 28, 2013
	Customer	Vendor
	Vendor	Customer
Financial Instruments [Line Items]	'	'
Maturities of long-term marketable securities, minimum	'1 year	'
Maturities of long-term marketable securities, maximum	'5 years	'
Range of time hedged in cash flow hedge	'The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.	'
Hedged transactions, expected occurrence	'12 months	'
Hedged interest rate transactions, expected occurrence	'5 years	'
Cash collateral posted, derivative instruments	'	$164
Cash collateral received, derivative instruments	165	'
Reduction to derivative assets by rights of set-off associated with derivative contracts	356	333
Reduction to derivative liabilities by rights of set-off associated with derivative contracts	356	333
Net derivative liability	$66	$57
Number of customers representing a significant portion of trade receivables	0	2
Customers representing a significant portion of trade receivables, description	'There were no customers that accounted for 10% or more of the Company's trade receivables as of December 28, 2013.	'As of September 28, 2013, the Company had two customers that represented 10% or more of total trade receivables, one of which accounted for 13% and the other 10%.
Number of vendors representing a significant portion of non-trade receivables	2	3
Customer One	'	'
Financial Instruments [Line Items]	'	'
Trade receivables from customer, percentage of total trade receivables	'	13.00%
Customer Two	'	'
Financial Instruments [Line Items]	'	'
Trade receivables from customer, percentage of total trade receivables	'	10.00%
Total Cellular Network Carriers	'	'
Financial Instruments [Line Items]	'	'
Trade receivables from customer, percentage of total trade receivables	48.00%	68.00%
Vendor One	'	'
Financial Instruments [Line Items]	'	'
Vendor non-trade receivables, as percentage of total non-trade receivable	62.00%	47.00%
Vendor Two	'	'
Financial Instruments [Line Items]	'	'
Vendor non-trade receivables, as percentage of total non-trade receivable	15.00%	21.00%
Vendor Three	'	'
Financial Instruments [Line Items]	'	'
Vendor non-trade receivables, as percentage of total non-trade receivable	'	15.00%

Notional_Principal_Amounts_of_

Notional Principal Amounts of Outstanding Derivative Instruments and Credit Risk Amounts Associated with Outstanding or Unsettled Derivative Instruments (Detail) (USD $)	Dec. 28, 2013	Sep. 28, 2013
In Millions, unless otherwise specified
Derivatives Designated as Hedging Instruments | Foreign exchange contracts	'	'
Derivative [Line Items]	'	'
Notional Principal	$23,553	$35,013
Credit Risk Amounts	331	159
Derivatives Designated as Hedging Instruments | Interest rate contract	'	'
Derivative [Line Items]	'	'
Notional Principal	3,000	3,000
Credit Risk Amounts	55	44
Not Designated as Hedging Instrument | Foreign exchange contracts	'	'
Derivative [Line Items]	'	'
Notional Principal	16,859	16,131
Credit Risk Amounts	$48	$25

Derivative_Instruments_at_Gros

Derivative Instruments at Gross Fair Value as Reflected in Condensed Consolidated Balance Sheets (Detail) (Level 2, USD $)	Dec. 28, 2013		Sep. 28, 2013
In Millions, unless otherwise specified
Other Current Assets	'		'
Derivative assets	'		'
Fair Value of Derivatives Designated as Hedge Instruments - Foreign exchange contracts	$263	[1]	$145	[1]
Fair Value of Derivatives Not Designated as Hedge Instruments - Foreign exchange contracts	48	[1]	25	[1]
Total Fair Value of Assets - Foreign exchange contracts	311	[1]	170	[1]
Fair Value of Derivatives Designated as Hedge Instruments - Interest rate contracts	55	[1]	44	[1]
Fair Value of Derivatives Not Designated as Hedge Instruments - Interest rate contracts	0	[1]	0	[1]
Total Fair Value of Assets - Interest rate contracts	55	[1]	44	[1]
Accrued expenses	'		'
Derivative liabilities	'		'
Fair Value of Derivatives Designated as Hedge Instruments - Foreign exchange contracts	231	[2]	389	[2]
Fair Value of Derivatives Not Designated as Hedge Instruments - Foreign exchange contracts	36	[2]	46	[2]
Total Fair Value of Liabilities - Foreign exchange contracts	$267	[2]	$435	[2]
[1]	The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance Sheets.
[2]	The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance Sheets.

PreTax_Effect_of_Derivative_In

Pre-Tax Effect of Derivative Instruments Designated as Cash Flow and Net Investment Hedges (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Gains (Losses) Recognized in OCI - Effective Portion	$309	$241
Gains (Losses) Reclassified from AOCI into Net Income - Effective Portion	-78	-159
Gains (Losses) Recognized - Ineffective Portion and Amount Excluded from Effectiveness Testing	-2	9
Cash flow hedges | Foreign exchange contracts	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Gains (Losses) Recognized in OCI - Effective Portion	264	205
Gains (Losses) Reclassified from AOCI into Net Income - Effective Portion	-74	-159
Gains (Losses) Recognized - Ineffective Portion and Amount Excluded from Effectiveness Testing	-3	9
Cash flow hedges | Interest rate contract	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Gains (Losses) Recognized in OCI - Effective Portion	21	0
Gains (Losses) Reclassified from AOCI into Net Income - Effective Portion	-4	0
Gains (Losses) Recognized - Ineffective Portion and Amount Excluded from Effectiveness Testing	0	0
Net investment hedges | Foreign exchange contracts	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Gains (Losses) Recognized in OCI - Effective Portion	24	36
Gains (Losses) Reclassified from AOCI into Net Income - Effective Portion	0	0
Gains (Losses) Recognized - Ineffective Portion and Amount Excluded from Effectiveness Testing	$1	$0

Inventory_Detail

Inventory (Detail) (USD $)	Dec. 28, 2013	Sep. 28, 2013
In Millions, unless otherwise specified
Inventory [Line Items]	'	'
Components	$523	$683
Finished goods	1,599	1,081
Total inventories	$2,122	$1,764

Property_Plant_and_Equipment_D

Property, Plant and Equipment (Detail) (USD $)	Dec. 28, 2013	Sep. 28, 2013
In Millions, unless otherwise specified
Property, Plant and Equipment [Line Items]	'	'
Gross property, plant and equipment	$29,288	$28,519
Accumulated depreciation and amortization	-13,800	-11,922
Net property, plant and equipment	15,488	16,597
Land and Building	'	'
Property, Plant and Equipment [Line Items]	'	'
Gross property, plant and equipment	3,625	3,309
Machinery, Equipment and Internal Use Software	'	'
Property, Plant and Equipment [Line Items]	'	'
Gross property, plant and equipment	21,537	21,242
Leasehold Improvements	'	'
Property, Plant and Equipment [Line Items]	'	'
Gross property, plant and equipment	$4,126	$3,968

Accrued_Expenses_Detail

Accrued Expenses (Detail) (USD $)	Dec. 28, 2013	Sep. 28, 2013	Dec. 29, 2012	Sep. 29, 2012
In Millions, unless otherwise specified
Schedule of Accrued Liabilities [Line Items]	'	'	'	'
Accrued warranty and related costs	$3,980	$2,967	$2,310	$1,638
Accrued taxes	2,083	1,200	'	'
Deferred margin on component sales	1,475	1,262	'	'
Accrued marketing and selling expenses	1,143	1,291	'	'
Accrued compensation and employee benefits	1,002	959	'	'
Other current liabilities	6,141	6,177	'	'
Total accrued expenses	$15,824	$13,856	'	'

NonCurrent_Liabilities_Detail

Non-Current Liabilities (Detail) (USD $)	Dec. 28, 2013	Sep. 28, 2013
In Millions, unless otherwise specified
Schedule of Other Liabilities [Line Items]	'	'
Deferred tax liabilities	$18,306	$16,489
Other non-current liabilities	3,393	3,719
Total other non-current liabilities	$21,699	$20,208

Other_Income_and_Expense_Detai

Other Income and Expense (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012
Other Income Expense [Line Items]	'	'
Interest and dividend income	$427	$421
Interest expense	-84	0
Other expense, net	-97	41
Total other income/(expense), net	$246	$462

Goodwill_and_Other_Intangible_2

Goodwill and Other Intangible Assets - Additional Information (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012
Acquired Finite-Lived Intangible Assets [Line Items]	'	'
Business acquisitions, aggregate cash consideration paid, net of cash acquired	$525	$284
Business acquisitions allocated to goodwill	440	'
Business acquisitions allocated to intangible assets	156	'
Business acquisitions allocated to net liabilities assumed	$71	'
Minimum	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'
Amortized acquired intangible assets with definite lives useful period (in years)	'3 years	'
Maximum	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'
Amortized acquired intangible assets with definite lives useful period (in years)	'7 years	'

Components_of_Gross_and_Net_In

Components of Gross and Net Intangible Asset Balances (Detail) (USD $)	Dec. 28, 2013	Sep. 28, 2013
In Millions, unless otherwise specified
Acquired Intangible Assets [Line Items]	'	'
Acquired Intangible Assets, Gross Carrying Amount	$6,371	$6,181
Acquired Intangible Assets, Accumulated Amortization	-2,266	-2,002
Acquired Intangible Assets, Net Carrying Amount	4,105	4,179
Definite lived and amortizable acquired intangible assets	'	'
Acquired Intangible Assets [Line Items]	'	'
Acquired Intangible Assets, Gross Carrying Amount	6,271	6,081
Acquired Intangible Assets, Accumulated Amortization	-2,266	-2,002
Acquired Intangible Assets, Net Carrying Amount	4,005	4,079
Indefinite lived and non-amortizable acquired intangible assets	'	'
Acquired Intangible Assets [Line Items]	'	'
Acquired Intangible Assets, Gross Carrying Amount	100	100
Acquired Intangible Assets, Accumulated Amortization	0	0
Acquired Intangible Assets, Net Carrying Amount	$100	$100

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	Dec. 28, 2013	Sep. 28, 2013
Income Taxes [Line Items]	'	'
Gross unrecognized tax benefits	$3,000,000,000	$2,700,000,000
Unrecognized tax benefits that would affect effective tax rate, if recognized	1,500,000,000	1,400,000,000
Unrecognized tax benefits, gross interest and penalties accrued	643,000,000	590,000,000
Reasonably possible reduction in unrecognized tax benefits in the next 12 months, minimum	'	140,000,000
Reasonably possible reduction in unrecognized tax benefits in the next 12 months, maximum	'	$160,000,000

LongTerm_Debt_Additional_Infor

Long-Term Debt - Additional Information (Detail) (USD $)	3 Months Ended
	Dec. 28, 2013
Debt Instrument [Line Items]	'
Debt instrument aggregate principal amount	$17,000,000,000
Interest expense	84,000,000
Aggregate unamortized discount	39,000,000
Floating-rate notes, due 2016	'
Debt Instrument [Line Items]	'
Debt instrument maturity year	'2016
Debt instrument LIBOR rate	0.05%
Floating-rate notes, due 2018	'
Debt Instrument [Line Items]	'
Debt instrument maturity year	'2018
Debt instrument LIBOR rate	0.25%
Cash flow hedges | Interest Rate Swap	'
Debt Instrument [Line Items]	'
Notional amount	3,000,000,000
Level 2	'
Debt Instrument [Line Items]	'
Debt instrument fair value	$15,800,000,000

Debt_Instruments_Principal_Amo

Debt Instruments Principal Amounts Associated With Effective Interest Rates (Detail) (USD $)	Dec. 28, 2013
In Millions, unless otherwise specified
Debt Instrument [Line Items]	'
Debt instrument aggregate principal amount	$17,000
Floating-rate notes, due 2016	'
Debt Instrument [Line Items]	'
Debt instrument, senior notes	1,000
Debt instrument effective interest rate	0.51%
Floating-rate notes, due 2018	'
Debt Instrument [Line Items]	'
Debt instrument, senior notes	2,000
Debt instrument effective interest rate	1.10%
Fixed-rate 0.45% notes due 2016	'
Debt Instrument [Line Items]	'
Debt instrument, senior notes	1,500
Debt instrument effective interest rate	0.51%
Fixed-rate 1.00% notes due 2018	'
Debt Instrument [Line Items]	'
Debt instrument, senior notes	4,000
Debt instrument effective interest rate	1.08%
Fixed-rate 2.40% notes due 2023	'
Debt Instrument [Line Items]	'
Debt instrument, senior notes	5,500
Debt instrument effective interest rate	2.44%
Fixed-rate 3.85% notes due 2043	'
Debt Instrument [Line Items]	'
Debt instrument, senior notes	$3,000
Debt instrument effective interest rate	3.91%

Debt_Instruments_Principal_Amo1

Debt Instruments Principal Amounts Associated With Effective Interest Rates (Parenthetical) (Detail)	Dec. 28, 2013
Floating-rate notes, due 2016	'
Debt Instrument [Line Items]	'
Debt instrument maturity year	'2016
Floating-rate notes, due 2018	'
Debt Instrument [Line Items]	'
Debt instrument maturity year	'2018
Fixed-rate 0.45% notes due 2016	'
Debt Instrument [Line Items]	'
Debt instrument interest rate	0.45%
Debt instrument maturity year	'2016
Fixed-rate 1.00% notes due 2018	'
Debt Instrument [Line Items]	'
Debt instrument interest rate	1.00%
Debt instrument maturity year	'2018
Fixed-rate 2.40% notes due 2023	'
Debt Instrument [Line Items]	'
Debt instrument interest rate	2.40%
Debt instrument maturity year	'2023
Fixed-rate 3.85% notes due 2043	'
Debt Instrument [Line Items]	'
Debt instrument interest rate	3.85%
Debt instrument maturity year	'2043

Debt_Instrument_Future_Princip

Debt Instrument Future Principal Payments (Detail) (USD $)	Dec. 28, 2013
In Millions, unless otherwise specified
Long Term Debt Maturities Repayments Of Principal [Line Items]	'
2014	$0
2015	0
2016	2,500
2017	0
2018	6,000
Thereafter	8,500
Total	$17,000

Shareholders_Equity_Additional

Shareholders' Equity - Additional Information (Detail) (USD $)	1 Months Ended	3 Months Ended	12 Months Ended		1 Months Ended	3 Months Ended	12 Months Ended	9 Months Ended
In Billions, except Share data in Millions, unless otherwise specified	Apr. 30, 2013	Dec. 28, 2013	Sep. 28, 2013	Sep. 29, 2012	Apr. 30, 2013	Dec. 29, 2012	Sep. 28, 2013	Jun. 29, 2013
					ASR 1	ASR 1	ASR 1	ASR 2
Stockholders Equity Note Disclosure [Line Items]	'	'	'	'	'	'	'	'
Preferred stock, shares authorized	'	5	'	'	'	'	'	'
Maximum amount authorized for repurchase of common stock	'	'	'	$10	'	'	'	'
New amount authorized for repurchase of common stock	60	'	'	'	'	'	'	'
Accelerated share repurchase program, utilized amount	'	28	'	'	'	'	'	'
Shares repurchased and retired	'	9.5	'	'	1.5	2.6	4.1	23.5
Accelerated share repurchase program, up-front payment	'	'	'	'	'	1.95	'	12
Shares repurchase program completion date	'	'	'April 2013	'	'	'	'	'
Shares repurchase price per share	'	'	'	'	'	'	$478.20	'
Shares retired, average price	'	$523.51	'	'	'	'	'	'
Shares retired Amount	'	$5	'	'	'	'	'	'

Summary_of_Dividends_Declared_

Summary of Dividends Declared and Paid (Detail) (USD $)	3 Months Ended					12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 28, 2013	Sep. 28, 2013	Jun. 29, 2013	Mar. 30, 2013	Dec. 29, 2012	Sep. 28, 2013
Dividends [Line Items]	'	'	'	'	'	'
Dividend Per Share	$3.05	$3.05	$3.05	$2.65	$2.65	$11.40
Amount	$2,739	$2,763	$2,789	$2,490	$2,486	$10,528

Gross_Amounts_Reclassified_fro

Gross Amounts Reclassified from AOCI into Condensed Consolidated Statements of Operations (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'
Unrecognized gains/losses on derivative instruments reclassified from AOCI	$88
Total amounts reclassified from AOCI	71
Other income/(expense), net	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'
Unrealized gains/losses on marketable securities reclassified from AOCI	-17
Foreign exchange contracts | Revenue	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'
Unrecognized gains/losses on derivative instruments reclassified from AOCI	184
Foreign exchange contracts | Cost of Sales	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'
Unrecognized gains/losses on derivative instruments reclassified from AOCI	-110
Foreign exchange contracts | Other income/(expense), net	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'
Unrecognized gains/losses on derivative instruments reclassified from AOCI	10
Interest rate contract | Other income/(expense), net	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'
Unrecognized gains/losses on derivative instruments reclassified from AOCI	$4

Change_in_Accumulated_Other_Co

Change in Accumulated Other Comprehensive Income by Component (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'
Beginning balance	($471)	'
Other comprehensive income/(loss) before reclassifications	103	'
Amounts reclassified from AOCI	71	'
Tax effect	-9	'
Total other comprehensive income/(loss)	165	113
Ending balance	-306	'
Cumulative Foreign Currency Translation	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'
Beginning balance	-105	'
Other comprehensive income/(loss) before reclassifications	-90	'
Amounts reclassified from AOCI	0	'
Tax effect	23	'
Total other comprehensive income/(loss)	-67	'
Ending balance	-172	'
Unrecognized Gains/Losses on Derivative Instruments	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'
Beginning balance	-175	'
Other comprehensive income/(loss) before reclassifications	261	'
Amounts reclassified from AOCI	88	'
Tax effect	-64	'
Total other comprehensive income/(loss)	285	'
Ending balance	110	'
Unrealized Gains/Losses on Marketable Securities	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'
Beginning balance	-191	'
Other comprehensive income/(loss) before reclassifications	-68	'
Amounts reclassified from AOCI	-17	'
Tax effect	32	'
Total other comprehensive income/(loss)	-53	'
Ending balance	($244)	'

Restricted_Stock_Units_Activit

Restricted Stock Units Activity and Related Information (Detail) (USD $)	3 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Dec. 28, 2013
Number of Restricted Stock Units	'
Beginning Balance	13,326
Restricted stock units granted	6,183
Restricted stock units vested	-2,256
Restricted stock units cancelled	-216
Ending Balance	17,037
Weighted-Average Grant Date Fair Value	'
Beginning Balance	$435.70
Restricted stock units granted	$491.93
Restricted stock units vested	$379.23
Restricted stock units cancelled	$461.35
Ending Balance	$463.23
Aggregate Intrinsic Value	'
Aggregate intrinsic value of Restricted stock units	$9,543

Benefit_Plans_Additional_Infor

Benefit Plans - Additional Information (Detail) (USD $)	3 Months Ended
	Dec. 28, 2013	Dec. 29, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Fair value of vested RSUs as of vesting date	$1,100,000,000	$1,500,000,000
Total intrinsic value of options at the time of exercise	559,000,000	347,000,000
Shares reserved for future issuance under stock plans (in shares)	16,600,000	'
Weighted-average grant date fair value	$333.26	$0
Weighted-average fair value of stock purchase rights per share	$103.99	$136.84
Income tax benefit related to share-based compensation expense	265,000,000	214,000,000
Total unrecognized compensation cost on stock options and RSUs	$6,600,000,000	'
Total unrecognized compensation cost on stock options and RSUs, weighted-average recognition period (in years)	'3 years 2 months 12 days	'
Business Combinations	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Weighted-average grant date fair value	'	$407.80
Stock Options Assumed	0	29,000

Stock_Option_Activity_and_Rela

Stock Option Activity and Related Information (Detail) (USD $)	3 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Dec. 28, 2013
Number of Options	'
Beginning Balance	4,094
Options granted	1
Options exercised	-1,308
Ending Balance	2,787
Exercisable at end of the period	2,768
Expected to vest after end of the period	19
Weighted-Average Exercise Price	'
Beginning Balance	$139.65
Options granted	$66.26
Options exercised	$102.86
Ending Balance	$156.89
Exercisable at end of the period	$157.56
Expected to vest after end of the period	$58.03
Weighted - Average Remaining Contractual Term (in years)	'
Ending Balance (in years)	'1 year 2 months 12 days
Exercisable at end of the period (in years)	'1 year 1 month 6 days
Expected to vest after end of the period (in years)	'7 years 7 months 6 days
Aggregate Intrinsic Value	'
Ending Balance	$1,124
Exercisable at end of the period	1,114
Expected to vest after end of the period	$10

Summary_of_ShareBased_Compensa

Summary of Share-Based Compensation Expense (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Share-based compensation expense	$681	$545
Cost of Sales	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Share-based compensation expense	109	85
Research and Development	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Share-based compensation expense	289	224
Selling, General and Administrative	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Share-based compensation expense	$283	$236

Changes_in_Accrued_Warranties_

Changes in Accrued Warranties and Related Costs (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012
Standard Product Warranty [Line Items]	'	'
Beginning accrued warranty and related costs	$2,967	$1,638
Cost of warranty claims	-1,064	-686
Accruals for product warranty	2,077	1,358
Ending accrued warranty and related costs	$3,980	$2,310

Commitments_and_Contingencies_1

Commitments and Contingencies - Additional Information (Detail) (USD $)	3 Months Ended	1 Months Ended
	Dec. 28, 2013	Nov. 06, 2012	Dec. 28, 2013	Aug. 24, 2012
		VirnetX, Inc.	Samsung Electronics Co Ltd	Samsung Electronics Co Ltd
Commitments and Contingencies Disclosure [Line Items]	'	'	'	'
Purchase commitments maximum period	'150 days	'	'	'
Maximum term of major facility leases	'10 years	'	'	'
Maximum additional term of renewal options on leases	'5 years	'	'	'
Minimum term of leases for retail space	'5 years	'	'	'
Maximum term of leases for retail space	'20 years	'	'	'
Majority of term of leases for retail space	'10 years	'	'	'
Total future minimum lease payments under noncancelable operating leases	$4,700,000,000	'	'	'
Future minimum lease payments under noncancelable operating leases related to leases for retail space	3,500,000,000	'	'	'
Outstanding off-balance sheet third party manufacturing commitments and component purchases commitments	16,100,000,000	'	'	'
Additional off-balance sheet obligation	1,500,000,000	'	'	'
Result of legal proceedings	'	'	930,000,000	1,050,000,000
Result of legal proceedings award up held	'	'	640,000,000	'
Result of legal proceedings awarded additional amount	'	'	290,000,000	'
Result of legal proceedings	'	$368,000,000	'	'

Summary_Information_by_Operati

Summary Information by Operating Segment (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012
Segment Reporting Information [Line Items]	'	'
Net sales	$57,594	$54,512
Operating income	17,463	17,210
Americas	'	'
Segment Reporting Information [Line Items]	'	'
Net sales	20,098	20,341
Operating income	7,266	7,349
Europe	'	'
Segment Reporting Information [Line Items]	'	'
Net sales	13,073	12,464
Operating income	4,576	4,409
Greater China	'	'
Segment Reporting Information [Line Items]	'	'
Net sales	8,844	6,830
Operating income	3,140	2,544
Japan	'	'
Segment Reporting Information [Line Items]	'	'
Net sales	4,948	4,443
Operating income	2,379	2,260
Rest of Asia Pacific	'	'
Segment Reporting Information [Line Items]	'	'
Net sales	3,633	3,993
Operating income	1,329	1,335
Retail	'	'
Segment Reporting Information [Line Items]	'	'
Net sales	6,998	6,441
Operating income	$1,744	$1,557

Reconciliation_of_Segment_Oper

Reconciliation of Segment Operating Income to Condensed Consolidated Financial Statements (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 28, 2013	Dec. 29, 2012
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'
Share-based compensation expense	($681)	($545)
Other corporate expenses, net	-2,290	-1,699
Operating income	17,463	17,210
Operating Segments	'	'
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'
Operating income	$20,434	$19,454